(Q37962420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

HIV/AIDS: 30 years of progress and future challenges (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Jay A Levy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

3401-3411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22125008%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Molecular cloning of AIDS-associated retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Global trends in molecular epidemiology of HIV-1 during 2000-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Biologic features of HIV-1 that correlate with virulence in the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Host factors involved in resistance to retroviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Human immunodeficiency virus, restriction factors, and interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV: Going for the watchman.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Structural variants of IFNα preferentially promote antiviral functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

The multiple functions of HIV-1 Tat: proliferation versus apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Mechanisms of HIV latency: an emerging picture of complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

21 January 2018

Acute HIV-1 Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Mechanisms of HIV-associated lymphocyte apoptosis: 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-1 immunopathogenesis: how good interferon turns bad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

CD8+ regulatory T cells in persistent human viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Protective HIV-specific CD8+ T cells evade Treg cell suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

The search for the CD8+ cell anti-HIV factor (CAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Protection from HIV/AIDS: the importance of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HLA/KIR restraint of HIV: surviving the fittest

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Adaptation of HIV-1 to human leukocyte antigen class I

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Tracking the killers: how should we measure CD8 T cells in HIV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Broad neutralization coverage of HIV by multiple highly potent antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

DCs and NK cells: critical effectors in the immune response to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Mature dendritic cells can enhance CD8+ cell noncytotoxic anti-HIV responses: the role of IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

The nature of the principal type 1 interferon-producing cells in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Natural type 1 interferon producing cells in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-1 adaptation to NK-cell-mediated immune pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

A whole-genome association study of major determinants for host control of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Host genetic polymorphisms associated with innate immune factors and HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Antiretroviral therapy and management of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Prevention of HIV-1 infection with early antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Ageing with HIV in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Curing HIV: Pharmacologic approaches to target HIV-1 latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Latent HIV in primary T lymphocytes is unresponsive to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

AIDS/HIV. Converging on an HIV vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-specific cytotoxic T lymphocytes in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021

Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Multicenter AIDS Cohort Study Group

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021

Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021

CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021

Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021

Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201142082

7 January 2021